Nmc Health (OTCMKTS:NMHLY) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday. The brokerage presently has a $49.00 price target on the stock. Zacks Investment Research‘s target price would indicate a potential upside of 12.96% from the company’s previous close.
According to Zacks, “NMC Health plc is an integrated private healthcare network operator primarily in the United Arab Emirates. The company also provides fertility treatments principally in European and Middle Eastern. NMC Health plc is based in London, the United Kingdom. “
Shares of Nmc Health (OTCMKTS:NMHLY) traded up $1.18 on Friday, reaching $43.38. 3,007 shares of the company’s stock were exchanged, compared to its average volume of 407. Nmc Health has a 1 year low of $21.59 and a 1 year high of $43.38.
COPYRIGHT VIOLATION WARNING: “Nmc Health (NMHLY) Upgraded to Buy by Zacks Investment Research” was reported by American Banking News and is the property of of American Banking News. If you are reading this news story on another domain, it was illegally copied and republished in violation of United States and international trademark & copyright law. The correct version of this news story can be read at https://www.americanbankingnews.com/2018/01/20/nmc-health-nmhly-upgraded-to-buy-by-zacks-investment-research.html.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nmc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nmc Health and related companies with MarketBeat.com's FREE daily email newsletter.